rs3760775 — FUT6
Near-gene regulatory variant near FUT6 that reduces fucosyltransferase expression and lowers circulating vitamin B12 — especially common in Indians
Details
- Gene
- FUT6
- Chromosome
- 19
- Risk allele
- G
- Consequence
- Regulatory
- Inheritance
- Additive
- Clinical
- Risk Factor
- Evidence
- Moderate
Population Frequency
Ancestry Frequencies
Tags
Related SNPs
Category
Nutrition & MetabolismSee your personal result for FUT6
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
FUT6 and Vitamin B12 — A Hidden Genetic Lever Common in South Asians
Vitamin B12 is essential for DNA synthesis, myelin formation, and one-carbon
metabolism, yet a striking proportion of Indians — estimated at 47–70% of
adults — have clinically low circulating B12 levels even when their diets are
not severely restricted. Part of this disparity has a genetic explanation: a
regulatory variant near the FUT6 gene that subtly suppresses
fucosyltransferase11 fucosyltransferase
An enzyme that attaches fucose sugar molecules to glycoproteins and glycolipids, influencing cell-surface signalling and microbial interactions
activity and, through that, lowers circulating B12.
The Mechanism
FUT6 encodes alpha-(1,3)-fucosyltransferase 6, a Golgi enzyme that synthesises
sialyl-Lewis X22 sialyl-Lewis X
A carbohydrate structure on cell surfaces that serves as a ligand for E-selectin and controls cell-cell adhesion, immune trafficking, and gut microbial colonisation
glycan structures. These fucosylated glycans line the intestinal epithelium and
serve as a biological interface between host cells and gut microbiota.
rs3760775 sits in a regulatory region near the FUT6 promoter/enhancer cluster on
chromosome 19p13.3. The G allele (the common allele in Europeans, the risk allele
here) is associated with lower FUT6 expression, while the T allele preserves
higher expression. The companion variant rs78060698 at the same locus has been
shown through luciferase reporter assays and electrophoretic mobility shift assays
to exhibit allele-specific promoter and enhancer activity, affecting binding of
HNF4α33 HNF4α
Hepatocyte Nuclear Factor 4α — a transcription factor that regulates expression of multiple fucosyltransferases and is highly expressed in the gut and liver,
a key regulator of fucosyltransferase expression in the gut.
The functional pathway linking FUT6 to B12 most likely runs through two routes:
first, altered intestinal fucosylation changes the gut microbiome composition,
affecting microbial B12 synthesis and uptake; second, fucosylation of
haptocorrin44 haptocorrin
Also called transcobalamin I — a glycoprotein that binds ~80% of circulating B12 but is metabolically inert; only the liver can extract B12 from it,
the dominant B12-binding protein in serum, may affect its hepatic clearance rate,
altering how much B12 remains in circulation.
The Evidence
The primary evidence comes from a 2017 GWAS by Nongmaithem et al.55 Nongmaithem et al.
Nongmaithem SS et al. GWAS identifies population-specific new regulatory variants in FUT6 associated with plasma B12 concentrations in Indians. Hum Mol Genet, 2017
conducted in 1,001 healthy participants from the Pune Maternal Nutrition Study with
replication in 3,418 Indians from independent cohorts (total n = 4,419). The T
allele at rs3760775 was associated with higher B12 levels at genome-wide
significance (meta-analysis beta = 0.25, P = 1.2×10⁻²³ on log-transformed B12).
The effect allele frequency was 0.27 in Indians versus only 0.06 in Europeans
(CEU), indicating the variant and its population impact are substantially higher
in South Asians.
Conditional analysis showed that rs3760775 captures the primary signal at this locus, with rs3760776 and rs78060698 tagging the same or overlapping signals in the FUT6 region. The association was replicated consistently across sex, age, pregnancy status, and ethnicity subgroups.
A large PLOS Genetics meta-analysis66 PLOS Genetics meta-analysis
Grarup N et al. Genetic Architecture of Vitamin B12 and Folate Levels Uncovered Applying Deeply Sequenced Large Datasets. PLoS Genet, 2013
confirmed the FUT6/FUT3 cluster as one of 11 B12-associated loci across
European and Icelandic populations. All identified loci together explain about
6.3% of B12 variance, consistent with polygenic architecture.
The mechanism was further illuminated by studies of the related FUT2 gene:
Rogne et al. 201777 Rogne et al. 2017
Rogne S et al. FUT2 secretor variant p.Trp154Ter influences serum vitamin B12 concentration via holo-haptocorrin. Hum Mol Genet, 2017
demonstrated that FUT2 non-secretors have 16–22% higher total B12 but unchanged
active B12 (holo-transcobalamin), because fucosylation affects haptocorrin
glycosylation and hepatic clearance, not intestinal uptake per se. A similar
mechanism likely operates at FUT6 — meaning the effect on total circulating B12
is real, but the clinically relevant fraction (active B12 delivered to tissues)
may differ from what total serum B12 tests show.
Practical Actions
If you carry two G alleles at rs3760775 (GG), your FUT6 expression is likely somewhat lower, reducing the fucosylation-dependent mechanisms that support B12 metabolism. Given that Indians already have high background rates of B12 deficiency partly explained by vegetarian diets, this genetic variant can compound dietary inadequacy. The most direct action is to ensure adequate B12 intake and to use the most bioavailable supplemental forms when needed.
For monitoring: serum total B12 may not fully reflect cellular B12 status when fucosylation-dependent haptocorrin clearance is altered. Holo-transcobalamin (active B12) or methylmalonic acid (MMA) testing provides a more accurate picture of functional B12 sufficiency.
Interactions
FUT6 rs3760775 acts additively with FUT2 rs601338 and rs602662 — both affect fucosylation in overlapping pathways. Carrying risk alleles at multiple FUT loci compounds the effect on B12 regulation. Additionally, B12 metabolism intersects with the folate-methylation cycle: low B12 elevates homocysteine, which in turn amplifies risks from MTHFR C677T (rs1801133) heterozygosity. The FUT3-FUT5-FUT6 gene cluster on 19p13.3 shows distinct linkage disequilibrium patterns across ethnicities, which is why this variant's impact is most pronounced in South Asian populations.
Nutrient Interactions
Genotype Interpretations
What each possible genotype means for this variant:
Both copies of the higher-B12 allele — optimal FUT6 expression
You carry two copies of the T allele, the variant associated with higher FUT6 expression and the highest circulating B12 levels at this locus. This genotype is rare in Europeans (about 0.4%) but found in roughly 7% of Indians. Your FUT6-mediated fucosylation is likely operating at full capacity, supporting normal gut microbial interactions and haptocorrin glycosylation. This does not guarantee B12 sufficiency — diet, FUT2 status, and other absorption-related factors still matter — but this locus is working in your favour.
One copy of the low-B12 allele — moderately reduced FUT6 expression
The GWAS discovery by Nongmaithem et al. (2017) showed an additive effect of the T allele on B12 levels (beta = 0.25 per allele on log-transformed B12), meaning each copy of the T allele raises B12 by approximately 25–28% of a standard deviation. GT carriers sit in the middle of this distribution.
Because FUT6 likely affects B12 through haptocorrin glycosylation rather than intestinal absorption directly, the total B12 your lab test measures may be misleading. Holo-transcobalamin (active B12) provides a cleaner readout of tissue-available B12. Methylmalonic acid (MMA) — a metabolite that accumulates when cellular B12 is insufficient — is the most sensitive functional marker.
Both copies of the low-B12 allele — lowest circulating B12 in this gene
Conditional analysis by Nongmaithem et al. (2017) confirmed rs3760775 as the primary signal in this chromosomal region, with the T allele raising log-B12 by ~0.25 units per copy. GG individuals lack both T alleles and thus show the lowest B12 at this locus. In the Pune Maternal Nutrition Study context, this was particularly meaningful given baseline B12 deficiency prevalence exceeding 50% in Indian adults.
The most plausible mechanism involves reduced alpha-(1,3)-fucosylation of haptocorrin, the glycoprotein that carries ~80% of circulating B12. Changes in haptocorrin glycosylation alter hepatic clearance rates, affecting measured serum B12 independently of absorption. The clinically actionable fraction is holo-transcobalamin (active B12), which represents B12 bound to transcobalamin and available to all tissues. Elevated methylmalonic acid is the downstream functional marker of cellular insufficiency.
Note that this variant acts additively with FUT2 secretor variants (rs601338, rs602662) — carrying risk alleles at both genes produces a compounded effect on B12 regulation.
Key References
Nongmaithem et al. 2017 — GWAS in 4,419 Indians identifying rs3760775 and rs78060698 in FUT6 associated with plasma B12 (P = 1.2×10⁻²³); allele frequency 0.27 vs 0.06 in Europeans
Grarup et al. 2013 — PLOS Genetics analysis of 11 B12-associated loci including the FUT6/FUT3 cluster, explaining 6.3% of B12 variance
Rogne et al. 2017 — FUT2 secretor variant influences B12 via holo-haptocorrin glycosylation rather than transcobalamin, clarifying the fucosyltransferase-B12 mechanism
Yajnik et al. 2018 — B12 deficiency is widespread in vegetarian Indians; genetic and dietary determinants interact